UPDATE : Thursday, August 13, 2020
상단여백
Covid-19 makes Vivozon halt P3 trial of nonnarcotic analgesics in US by Lee Han-soo 2020-08-13 17:27
Takeda expects more effective IBD treatment with Kynteles' expanded reimbursement by Lee Han-soo 2020-08-12 17:45
Roche’s Tecentriq-Avastin combo wins nod to treat hepatocellular carcinoma by Lee Han-soo 2020-08-12 14:35
Daewoong to conduct P1 trial of Covid-19 treatment in India by Lee Han-soo 2020-08-11 17:48
Curocell draws $37-million investment, steps up trials of CAR-T therapy by Park Gi-taek 2020-08-10 17:28
라인
Rheumatoid arthritis drug Rinvoq gets insurance benefit by Kim Eun-young 2020-08-07 14:34
Regulator OKs Pfizer's BRCA mutation breast cancer treatment by Lee Han-soo 2020-08-05 16:02
Hanmi, MSD sign licensing agreement for hepatitis treatment by Shim Hyun-tai 2020-08-05 15:24
Korean biopharmaceutical market expands on biosimilar export growth by Kim Chan-hyuk 2020-08-04 15:46
Medpacto to unveil trial results at European conference by Lee Han-soo 2020-08-04 14:44
라인
Drugmakers tap home fitness market amid Covid-19 by Kim Chan-hyuk 2020-08-04 11:22
Medpacto to develop test kit for metastatic breast cancer by Shim Hyun-tai 2020-08-03 17:51
AbbVie’s hepatitis C drug Maviret gets expanded regulatory nod by Shim Hyun-tai 2020-08-03 17:51
Boryung’s SCLC treatment wins orphan drug status by Lee Han-soo 2020-08-03 16:48
Daewoong's Q2 earnings plummet amid legal battle with Medytox by Lee Han-soo 2020-07-31 16:58
라인
"Multinational pharma use illegal kickbacks to benefit executives, headquarters" by Kim Yun-mi, Lee Han-soo 2020-07-31 13:54
‘Nabota alleviates sleep bruxism’ by Lee Han-soo 2020-07-30 17:23
Hugel to export HA filler to Indonesia by Lee Han-soo 2020-07-29 17:23
GC applies for P2 trials of plasma therapy for Covid-19 by Lee Han-soo 2020-07-29 14:45
GC Labcell turns profitable in Q2 by Lee Han-soo 2020-07-28 14:11
여백
여백
여백
Back to Top